# RNAZ catalysts: Transcode Therapeutics, Inc. PDUFA dates and FDA events

Canonical: https://sec-api.dev/companies/rnaz/catalysts

> Transcode Therapeutics, Inc. (RNAZ) has no upcoming catalysts in this calendar. The latest recorded is the arrows trial start, Sep 2024.

Data as of November 16, 2026 (snapshot 20261116T222116Z). Every date quotes the SEC filing or FDA page it came from. Date precision: month only.

**Free:** every drug page and the next 30 days of the FDA calendar, no account. Calendar API, alerts when a date moves, and full history: https://sec-api.dev/pricing . Free API key: https://sec-api.dev/sign-up?ref=ai-claudebot

## Company

| Field | Value |
| --- | --- |
| Name | Transcode Therapeutics, Inc. |
| Ticker | RNAZ (Nasdaq) |
| SEC CIK | 1829635 |
| SIC | 2834 |
| SEC filings | https://sec-api.dev/companies/rnaz |

## Cash runway

Cash $8.4M as of 2026-06-30; quarterly burn $5.4M; about 4.7 months of runway at that rate (XBRL company facts, accession 0001829635-26-000003).

## Catalysts

| Date | Event | Ticker | Indication | Status | Source sentence |
| --- | --- | --- | --- | --- | --- |
| Sep 2024 | [Arrows trial start](https://sec-api.dev/pdufa/arrows) | RNAZ |  | completed | "In September 2024, we commenced a Phase I/II clinical trial with TTX-MC138 which substantially met its primary safety endpoint by the end of 2025." ([SEC Form 10-Q](https://www.sec.gov/Archives/edgar/data/1829635/000182963526000003/rnaz-20260630x10q.htm)) |

## Drugs

- [Arrows](https://sec-api.dev/pdufa/arrows): 

## Feeds and downloads

- Subscribe (iCal): https://sec-api.dev/companies/rnaz/catalysts.ics
- Next 30 days as CSV: https://sec-api.dev/fda-calendar.csv . JSON: https://sec-api.dev/fda-calendar.json . All events (iCal): https://sec-api.dev/fda-calendar.ics
- New or moved PDUFA dates: https://sec-api.dev/pdufa-dates/feed.xml (RSS), https://sec-api.dev/pdufa-dates/feed.json (JSON Feed)
- FDA approvals: https://sec-api.dev/fda-approvals-today/feed.xml (RSS), https://sec-api.dev/fda-approvals-today/feed.json (JSON Feed)
- License: CC BY 4.0 for the public 30-day window (https://sec-api.dev/biotech/license.txt). Full history: https://sec-api.dev/pricing

## Cite this page

sec-api.dev. "RNAZ catalysts: Transcode Therapeutics, Inc. PDUFA dates and FDA events." Biotech catalyst calendar, data as of November 16, 2026 (snapshot 20261116T222116Z). https://sec-api.dev/companies/rnaz/catalysts

```bibtex
@misc{secapidev_companies_rnaz_catalysts_20261116,
  title        = {RNAZ catalysts: Transcode Therapeutics, Inc. PDUFA dates and FDA events},
  author       = {{sec-api.dev}},
  year         = {2026},
  month        = {nov},
  howpublished = {\url{https://sec-api.dev/companies/rnaz/catalysts}},
  note         = {Biotech catalyst calendar, data as of 2026-11-16, snapshot 20261116T222116Z. Compiled from SEC EDGAR filings, FDA and ClinicalTrials.gov; each date quotes its source.}
}
```

```json
{"type":"dataset","id":"secapidev_companies_rnaz_catalysts_20261116","title":"RNAZ catalysts: Transcode Therapeutics, Inc. PDUFA dates and FDA events","publisher":"sec-api.dev","URL":"https://sec-api.dev/companies/rnaz/catalysts","issued":{"date-parts":[[2026,11,16]]},"version":"20261116T222116Z","license":"https://creativecommons.org/licenses/by/4.0/","note":"Compiled from SEC EDGAR filings, FDA and ClinicalTrials.gov; each date quotes its source."}
```

---
Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Food and Drug Administration or the U.S. Securities and Exchange Commission. Dates are as stated by sponsors and FDA; the FDA can act before or after a target date. Not investment advice.
